(kar-MUS-teen)
This page contains brief information about carmustine and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Carmustine is approved to be used alone or with other drugs to treat:
- Brain tumors (certain types).
- Hodgkin lymphoma. It is used with other drugs in patients whose disease has not gotten better with other treatment or has recurred (come back).
- Multiple myeloma. It is used with prednisone.
- Non-Hodgkin lymphoma. It is used with other drugs in patients whose disease has not gotten better with other treatment or has recurred (come back).
Carmustine is also being studied in the treatment of other types of cancer.
Carmustine is also available in a different form called carmustine implant. For more information, see the Drug Information Summary for Carmustine Implant.
More About Carmustine
Definition from the NCI Drug Dictionary – Detailed scientific definition and other names for this drug.
More About Carmustine – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Carmustine – Check for trials from NCI’s list of cancer clinical trials now accepting patients.
